XORTX Therapeutics Inc. (XRTX)
NASDAQ: XRTX · Real-Time Price · USD
0.9900
-0.0100 (-1.00%)
At close: Nov 4, 2026, 4:00 PM EST
0.9603
-0.0297 (-3.00%)
Pre-market: Nov 5, 2026, 4:44 AM EST

XORTX Therapeutics Statistics

Total Valuation

XRTX has a market cap or net worth of $1.80 million. The enterprise value is $804,354.

Market Cap1.80M
Enterprise Value 804,354

Important Dates

The next estimated earnings date is Monday, November 16, 2026, after market close.

Earnings Date Nov 16, 2026
Ex-Dividend Date n/a

Share Statistics

XRTX has 1.82 million shares outstanding. The number of shares has increased by 93.11% in one year.

Current Share Class 1.82M
Shares Outstanding 1.82M
Shares Change (YoY) +93.11%
Shares Change (QoQ) +16.18%
Owned by Insiders (%) 1.39%
Owned by Institutions (%) 10.49%
Float 1.79M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.31
P/TBV Ratio 0.61
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.59, with zero debt.

Current Ratio 3.59
Quick Ratio 1.59
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -99.24% and return on invested capital (ROIC) is -34.99%.

Return on Equity (ROE) -99.24%
Return on Assets (ROA) -29.85%
Return on Invested Capital (ROIC) -34.99%
Return on Capital Employed (ROCE) -38.72%
Weighted Average Cost of Capital (WACC) 8.72%
Revenue Per Employee n/a
Profits Per Employee -$1.25M
Employee Count3
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -69.01% in the last 52 weeks. The beta is 0.81, so XRTX's price volatility has been lower than the market average.

Beta (5Y) 0.81
52-Week Price Change -69.01%
50-Day Moving Average 1.66
200-Day Moving Average 2.10
Relative Strength Index (RSI) 34.44
Average Volume (20 Days) 1,607,137

Short Selling Information

The latest short interest is 237,048, so 13.05% of the outstanding shares have been sold short.

Short Interest 237,048
Short Previous Month 61,535
Short % of Shares Out 13.05%
Short % of Float 13.23%
Short Ratio (days to cover) 0.13

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -2.13M
Pretax Income -3.74M
Net Income -3.74M
EBITDA -2.15M
EBIT -2.13M
Earnings Per Share (EPS) -$2.83
Full Income Statement

Balance Sheet

The company has $994,045 in cash and no debt, with a net cash position of $994,045 or $0.55 per share.

Cash & Cash Equivalents 994,045
Total Debt n/a
Net Cash 994,045
Net Cash Per Share $0.55
Equity (Book Value) 5.50M
Book Value Per Share 3.18
Working Capital 1.76M
Full Balance Sheet

Cash Flow

Operating Cash Flow -5.10M
Capital Expenditures n/a
Depreciation & Amortization -14,797
Net Borrowing -80,473
Free Cash Flow -5.10M
FCF Per Share -$2.81
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

XRTX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -93.11%
Shareholder Yield -93.11%
Earnings Yield -285.37%
FCF Yield -283.61%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on April 6, 2026. It was a reverse split with a ratio of 1:5.

Last Split Date Apr 6, 2026
Split Type Reverse
Split Ratio 1:5

Scores

Altman Z-Score n/a
Piotroski F-Score 1